• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Novel 5' fusion partners of ETV1 and ETV4 in prostate cancer.前列腺癌中 ETV1 和 ETV4 的新型 5'融合伙伴。
Neoplasia. 2013 Jul;15(7):720-6. doi: 10.1593/neo.13232.
2
A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer.一项用于检测E26转化特异性畸变的荧光原位杂交筛查:前列腺癌中DDX5-ETV4融合蛋白的鉴定。
Cancer Res. 2008 Sep 15;68(18):7629-37. doi: 10.1158/0008-5472.CAN-08-2014.
3
Novel RNA hybridization method for the in situ detection of ETV1, ETV4, and ETV5 gene fusions in prostate cancer.用于原位检测前列腺癌中ETV1、ETV4和ETV5基因融合的新型RNA杂交方法。
Appl Immunohistochem Mol Morphol. 2014 Sep;22(8):e32-40. doi: 10.1097/PAI.0000000000000095.
4
Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts.共过表达细胞环境揭示ETV1和ETV4在前列腺癌侵袭性中的特异性和冗余活性。
Oncotarget. 2015 Mar 10;6(7):5217-36. doi: 10.18632/oncotarget.2847.
5
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.不同类型的染色体重排会在前列腺癌中产生致癌性ETS基因融合。
Nature. 2007 Aug 2;448(7153):595-9. doi: 10.1038/nature06024.
6
Comprehensive Determination of Prostate Tumor ETS Gene Status in Clinical Samples Using the CLIA Decipher Assay.使用CLIA解密检测法对临床样本中的前列腺肿瘤ETS基因状态进行综合测定。
J Mol Diagn. 2017 May;19(3):475-484. doi: 10.1016/j.jmoldx.2017.01.007. Epub 2017 Mar 21.
7
Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer.前列腺癌中TMPRSS2:ETV5和SLC45A3:ETV5基因融合的特征分析
Cancer Res. 2008 Jan 1;68(1):73-80. doi: 10.1158/0008-5472.CAN-07-5352.
8
FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer.FLI1 是一种新型 ETS 转录因子,参与前列腺癌中的基因融合。
Genes Chromosomes Cancer. 2012 Mar;51(3):240-9. doi: 10.1002/gcc.20948. Epub 2011 Nov 12.
9
TMPRSS2:ETS fusions and clinicopathologic characteristics of prostate cancer patients from Eastern China.中国东部前列腺癌患者的TMPRSS2:ETS融合与临床病理特征
Asian Pac J Cancer Prev. 2014;15(7):3099-103. doi: 10.7314/apjcp.2014.15.7.3099.
10
The utility of ETV1, ETV4 and ETV5 RNA in-situ hybridization in the diagnosis of CIC-DUX sarcomas.ETV1、ETV4和ETV5 RNA原位杂交在CIC-DUX肉瘤诊断中的应用
Histopathology. 2017 Mar;70(4):657-663. doi: 10.1111/his.13112. Epub 2016 Dec 16.

引用本文的文献

1
Oncogenic Fusions Harboring Genes: Exploring Novel Targetable Opportunities in Prostate Cancer.携带基因的致癌融合:探索前列腺癌新的可靶向治疗机会
Cancers (Basel). 2025 May 14;17(10):1657. doi: 10.3390/cancers17101657.
2
Exploring therapeutic applications of fusion, and tumour molecular subtypes in prostate cancer management.探索融合以及肿瘤分子亚型在前列腺癌治疗中的应用。
Front Oncol. 2025 Mar 17;15:1521204. doi: 10.3389/fonc.2025.1521204. eCollection 2025.
3
Development and characterization of an ETV1 rabbit monoclonal antibody for the immunohistochemical detection of ETV1 expression in cancer tissue specimens.一种用于检测癌症组织标本中 ETV1 表达的 ETV1 兔单克隆抗体的开发和鉴定。
J Immunol Methods. 2023 Jul;518:113493. doi: 10.1016/j.jim.2023.113493. Epub 2023 May 16.
4
Analysis of rare driving events in pediatric acute myeloid leukemia.分析儿科急性髓细胞白血病中的罕见驱动事件。
Haematologica. 2023 Jan 1;108(1):48-60. doi: 10.3324/haematol.2021.280250.
5
Concurrent CDX2 cis-deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL.同时存在的 CDX2 基因内调控区异常和 UBTF::ATXN7L3 融合定义了一种新型的 B 细胞急性淋巴细胞白血病的高危亚型。
Blood. 2022 Jun 16;139(24):3505-3518. doi: 10.1182/blood.2021014723.
6
Overview of research on fusion genes in prostate cancer.前列腺癌融合基因的研究综述
Transl Cancer Res. 2020 Mar;9(3):1998-2011. doi: 10.21037/tcr.2020.01.34.
7
E26 transformation-specific variant 4 as a tumor promotor in human cancers through specific molecular mechanisms.E26转化特异性变体4通过特定分子机制在人类癌症中作为肿瘤促进因子。
Mol Ther Oncolytics. 2021 Jul 29;22:518-527. doi: 10.1016/j.omto.2021.07.012. eCollection 2021 Sep 24.
8
Function and regulation of the PEA3 subfamily of ETS transcription factors in cancer.ETS转录因子PEA3亚家族在癌症中的功能与调控
Am J Cancer Res. 2020 Oct 1;10(10):3083-3105. eCollection 2020.
9
Dysregulation of cancer genes by recurrent intergenic fusions.基因间重排导致的癌症基因失调。
Genome Biol. 2020 Jul 6;21(1):166. doi: 10.1186/s13059-020-02076-2.
10
Comparison of four next generation sequencing platforms for fusion detection: Oncomine by ThermoFisher, AmpliSeq by illumina, FusionPlex by ArcherDX, and QIAseq by QIAGEN.用于融合检测的四种下一代测序平台的比较:赛默飞世尔科技的Oncomine、Illumina的AmpliSeq、ArcherDX的FusionPlex以及QIAGEN的QIAseq。
Cancer Genet. 2020 May;243:11-18. doi: 10.1016/j.cancergen.2020.02.007. Epub 2020 Mar 7.

本文引用的文献

1
Three-dimensional genome architecture influences partner selection for chromosomal translocations in human disease.三维基因组结构影响人类疾病中染色体易位的伙伴选择。
PLoS One. 2012;7(9):e44196. doi: 10.1371/journal.pone.0044196. Epub 2012 Sep 28.
2
Molecular subtyping of primary prostate cancer reveals specific and shared target genes of different ETS rearrangements.原发性前列腺癌的分子亚型揭示了不同 ETS 重排的特定和共有靶基因。
Neoplasia. 2012 Jul;14(7):600-11. doi: 10.1593/neo.12600.
3
Identification of androgen-regulated genes in human prostate.鉴定人前列腺中的雄激素调节基因。
Mol Med Rep. 2012 Sep;6(3):466-72. doi: 10.3892/mmr.2012.956. Epub 2012 Jun 19.
4
Identification of novel androgen-regulated pathways and mRNA isoforms through genome-wide exon-specific profiling of the LNCaP transcriptome.通过对 LNCaP 转录组的全基因组外显子特异性分析鉴定新型雄激素调控途径和 mRNA 异构体。
PLoS One. 2011;6(12):e29088. doi: 10.1371/journal.pone.0029088. Epub 2011 Dec 14.
5
FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer.FLI1 是一种新型 ETS 转录因子,参与前列腺癌中的基因融合。
Genes Chromosomes Cancer. 2012 Mar;51(3):240-9. doi: 10.1002/gcc.20948. Epub 2011 Nov 12.
6
Relative 8q gain predicts disease-specific survival irrespective of the TMPRSS2-ERG fusion status in diagnostic biopsies of prostate cancer.在前列腺癌的诊断性活检中,相对 8q 增益可预测疾病特异性生存,而与 TMPRSS2-ERG 融合状态无关。
Genes Chromosomes Cancer. 2011 Aug;50(8):662-71. doi: 10.1002/gcc.20888. Epub 2011 May 16.
7
Overexpression of full-length ETV1 transcripts in clinical prostate cancer due to gene translocation.临床前列腺癌中由于基因易位导致全长 ETV1 转录本的过表达。
PLoS One. 2011 Jan 26;6(1):e16332. doi: 10.1371/journal.pone.0016332.
8
Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements.雄激素诱导的 TOP2B 介导的双链断裂和前列腺癌基因重排。
Nat Genet. 2010 Aug;42(8):668-75. doi: 10.1038/ng.613. Epub 2010 Jul 4.
9
Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer.核受体诱导的染色体接近和 DNA 断裂是癌症中特定易位的基础。
Cell. 2009 Dec 11;139(6):1069-83. doi: 10.1016/j.cell.2009.11.030.
10
ETS gene fusions in prostate cancer.ETS 基因融合与前列腺癌。
Nat Rev Urol. 2009 Aug;6(8):429-39. doi: 10.1038/nrurol.2009.127.

前列腺癌中 ETV1 和 ETV4 的新型 5'融合伙伴。

Novel 5' fusion partners of ETV1 and ETV4 in prostate cancer.

机构信息

Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.

出版信息

Neoplasia. 2013 Jul;15(7):720-6. doi: 10.1593/neo.13232.

DOI:10.1593/neo.13232
PMID:23814484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3689235/
Abstract

Gene fusions involving the erythroblast transformation-specific (ETS) transcription factors ERG, ETV1, ETV4, ETV5, and FLI1 are a common feature of prostate carcinomas (PCas). The most common upstream fusion partner described is the androgen-regulated prostate-specific gene TMPRSS2, most frequently with ERG, but additional 5' fusion partners have been described. We performed 5' rapid amplification of cDNA ends in 18 PCas with ETV1, ETV4, or ETV5 outlier expression to identify the 5' fusion partners. We also evaluated the exon-level expression profile of these ETS genes in 14 cases. We identified and confirmed by fluorescent in situ hybridization (FISH) and reverse transcription-polymerase chain reaction the two novel chimeric genes OR51E2-ETV1 and UBTF-ETV4 in two PCas. OR51E2 encodes a G-protein-coupled receptor that is overexpressed in PCas, whereas UBTF is a ubiquitously expressed gene encoding an HMG-box DNA-binding protein involved in ribosome biogenesis. We additionally describe two novel gene fusion combinations of previously described genes, namely, SLC45A3-ETV4 and HERVK17-ETV4. Finally, we found one PCa with TMPRSS2-ETV1, one with C15orf21-ETV1, one with EST14-ETV1, and two with 14q133-q21.1-ETV1. In nine PCas (eight ETV1 and one ETV5), exhibiting ETS outlier expression and genomic rearrangement detected by FISH, no 5' fusion partner was found. Our findings contribute significantly to characterize the heterogeneous group of ETS gene fusions and indicate that all genes described as 5' fusion partners with one ETS gene can most likely be rearranged with any of the other ETS genes involved in prostate carcinogenesis.

摘要

涉及红细胞生成素转化特异性(ETS)转录因子 ERG、ETV1、ETV4、ETV5 和 FLI1 的基因融合是前列腺癌(PCa)的一个常见特征。描述的最常见的上游融合伙伴是雄激素调节的前列腺特异性基因 TMPRSS2,最常与 ERG 融合,但也描述了其他 5' 融合伙伴。我们对 18 例 ETV1、ETV4 或 ETV5 表达异常的 PCa 进行了 5' 快速 cDNA 末端扩增,以确定 5' 融合伙伴。我们还评估了这 14 例 ETS 基因的外显子水平表达谱。我们通过荧光原位杂交(FISH)和逆转录-聚合酶链反应(RT-PCR)鉴定并证实了两个新的嵌合基因 OR51E2-ETV1 和 UBTF-ETV4 在两个 PCa 中。OR51E2 编码一种 G 蛋白偶联受体,在 PCa 中过度表达,而 UBTF 是一种广泛表达的基因,编码一种参与核糖体生物发生的 HMG 盒 DNA 结合蛋白。我们还描述了两个先前描述的基因的新基因融合组合,即 SLC45A3-ETV4 和 HERVK17-ETV4。最后,我们发现一个 PCa 中有 TMPRSS2-ETV1,一个中有 C15orf21-ETV1,一个中有 EST14-ETV1,两个中有 14q133-q21.1-ETV1。在 9 例(8 例 ETV1 和 1 例 ETV5)表现出 FISH 检测到的 ETS 异常表达和基因组重排的 PCa 中,未发现 5' 融合伙伴。我们的研究结果对描述 ETS 基因融合的异质群体有重要贡献,并表明与一种 ETS 基因描述为 5' 融合伙伴的所有基因很可能与参与前列腺癌发生的其他 ETS 基因发生重排。